Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.

Cristian C AragónIván Posso-OsorioGermán PuertaJuan-David GonzálezJuan-Camilo NaranjoAlex EcheverriEliana OrtízIvana Nieto-AristizábalMaría Claudia BarreraLady J Ríos-SernaGabriel J Tobón

Published in: Clinical rheumatology (2020)

• In a Latin American cohort, the anti-DFS70 was higher in individuals without autoimmune diseases compared with that in patients with SLE.• The anti-DFS70 might have utility as a biomarker of exclusion in patients with non-specific clinical signs of AARDs.

Keyphrases

systemic lupus erythematosus
risk factors
rheumatoid arthritis
disease activity